MktsMarkets

Assembly Biosciences, Inc.
NASDAQ: ASMBKey statistics
ASMB News
Stories mentioning ASMB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Operating Expenses | ||||||||
| Research & Development | 14,900 | 17,250 | 16,587 | 16,125 | 14,851 | 14,280 | 13,515 | 16,259 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 19,583 | 22,670 | 21,672 | 20,719 | 19,360 | 18,889 | 17,801 | 20,736 |
| Operating Income (Loss) | (11,370) | 19,799 | (10,883) | (11,093) | (9,941) | (11,532) | (10,956) | (12,203) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (9,196) | (10,198) | (9,613) | (10,746) | ||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 406.00 | ||||
| Net Income (Loss) | (9,079) | 22,090 | (9,196) | (10,198) | (8,818) | (10,335) | (9,613) | (11,152) |
| Earnings Per Share (Basic) | (0.54) | 1.97 | (0.72) | (1.33) | (1.17) | (1.72) | (1.51) | (1.98) |
| Earnings Per Share (Diluted) | (0.54) | 1.97 | (0.72) | (1.33) | (1.17) | (1.72) | (1.51) | (1.98) |
| Weighted Average Shares Outstanding (Basic) | 16,900 | 11,211 | 12,686 | 7,656 | 7,506 | 6,005 | 6,351 | 5,643 |
| Weighted Average Shares Outstanding (Diluted) | 16,900 | 11,211 | 12,686 | 7,656 | 7,506 | 6,005 | 6,351 | 5,643 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ASMB
Assembly Biosciences, Inc. (NASDAQ: ASMB) is a stock listed on the Nasdaq Stock Market under the ticker symbol ASMB. It last traded at $20.13 (Oct 30, 2026, 4:00 PM ET), down 3.5% on the day. That gives Assembly Biosciences a market capitalisation of $408.4M.
Over the past 52 weeks ASMB has traded between $19.30 and $39.70.
For the quarter ended Mar 31, 2026 it reported a net loss of $9.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$9.1M |
| Dec 31, 2025 | — | $22.1M |
| Sep 30, 2025 | — | -$9.2M |
| Jun 30, 2025 | — | -$10.2M |
From Assembly Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…